Enphase Energy (ENPH) had the highest return between January 1, 2020 and February 20, 2020 by a mid-cap US stock, returning 122.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Enphase Energy (ENPH) | 1/1/2020 - 2/20/2020 | 122.75% |
Sunrun (RUN) | 1/1/2020 - 2/20/2020 | 67.26% |
Bloom Energy (BE) | 1/1/2020 - 2/20/2020 | 66.93% |
Appian (APPN) | 1/1/2020 - 2/20/2020 | 62.09% |
Bill Com (BILL) | 1/1/2020 - 2/20/2020 | 56.7% |
Twist Bioscience (TWST) | 1/1/2020 - 2/20/2020 | 56.13% |
Magnite (MGNI) | 1/1/2020 - 2/20/2020 | 54.92% |
Avis Budget (CAR) | 1/1/2020 - 2/20/2020 | 54.65% |
Zai Lab (ZLAB) | 1/1/2020 - 2/20/2020 | 50.44% |
Tandem Diabetes Care (TNDM) | 1/1/2020 - 2/20/2020 | 50.3% |
Penn National Gaming (PENN) | 1/1/2020 - 2/20/2020 | 46.98% |
Cytokinetics (CYTK) | 1/1/2020 - 2/20/2020 | 45.58% |
Bilibili (BILI) | 1/1/2020 - 2/20/2020 | 43.5% |
Ringcentral (RNG) | 1/1/2020 - 2/20/2020 | 43.39% |
TG Therapeutics (TGTX) | 1/1/2020 - 2/20/2020 | 42.39% |
Century Communities (CCS) | 1/1/2020 - 2/20/2020 | 41.38% |
Signet Jewelers (SIG) | 1/1/2020 - 2/20/2020 | 41.14% |
Denali Therapeutics (DNLI) | 1/1/2020 - 2/20/2020 | 41.06% |
Ultragenyx (RARE) | 1/1/2020 - 2/20/2020 | 40.92% |
CLARIVATE (CLVT) | 1/1/2020 - 2/20/2020 | 37.13% |
Agilysys (AGYS) | 1/1/2020 - 2/20/2020 | 37.04% |
Catalyst Pharmaceuticals (CPRX) | 1/1/2020 - 2/20/2020 | 36.84% |
Arcadium Lithium (ALTM) | 1/1/2020 - 2/20/2020 | 36.79% |
SLM (SLM) | 1/1/2020 - 2/20/2020 | 36.75% |
Merus (MRUS) | 1/1/2020 - 2/20/2020 | 36.1% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
